{
  "trial_id": "NCT00556933",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, primary cause of end-stage renal disease, duration of dialysis before transplantation, donor type (living or deceased), HLA matching, Panel Reactive Antibody (PRA) score, history of diabetes, body mass index (BMI), baseline renal function, previous immunosuppressive treatments, history of CMV disease, hepatitis B and C status, history of BK virus, allergy to rabbits, number of previous transplants, simultaneous kidney/pancreas transplantation status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Patient Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Donor type",
          "donor type (living or deceased)"
        ],
        [
          "Patient Panel Reactive Antibody (PRA)(%)",
          "Panel Reactive Antibody (PRA) score"
        ],
        [
          "Donor/Recipient High-Risk CMV Serostatus",
          "history of CMV disease"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Deceased-donor Cold Ischemia Time",
        "Donor/recipient height ratio",
        "Donor age",
        "Donor gender",
        "Donor BMI",
        "Donor final serum creatinine",
        "Adult Cadaver Donor Nyberg Grade",
        "Pediatric vs. Adult Donor"
      ],
      "remaining_candidate_features": [
        "primary cause of end-stage renal disease",
        "duration of dialysis before transplantation",
        "HLA matching",
        "history of diabetes",
        "baseline renal function",
        "previous immunosuppressive treatments",
        "hepatitis B and C status",
        "history of BK virus",
        "allergy to rabbits",
        "number of previous transplants",
        "simultaneous kidney/pancreas transplantation status."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Primary Renal Disease, Panel Reactive Antibody (PRA) Score, Donor Type, Time on Dialysis, HLA Mismatch, Cold Ischemia Time, Warm Ischemia Time, Pre-transplant Diabetes, Pre-transplant Hypertension, Pre-transplant Cardiovascular Disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Patient Panel Reactive Antibody (PRA)(%)",
          "Panel Reactive Antibody (PRA) Score"
        ],
        [
          "Donor type",
          "Donor Type"
        ],
        [
          "Deceased-donor Cold Ischemia Time",
          "Cold Ischemia Time"
        ]
      ],
      "remaining_reference_features": [
        "Patient Body Mass Index (BMI)",
        "Donor/recipient height ratio",
        "Donor age",
        "Donor gender",
        "Donor BMI",
        "Donor final serum creatinine",
        "Adult Cadaver Donor Nyberg Grade",
        "Pediatric vs. Adult Donor",
        "Donor/Recipient High-Risk CMV Serostatus"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Primary Renal Disease",
        "Time on Dialysis",
        "HLA Mismatch",
        "Warm Ischemia Time",
        "Pre-transplant Diabetes",
        "Pre-transplant Hypertension",
        "Pre-transplant Cardiovascular Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Cause of End-Stage Renal Disease, Duration of Dialysis, Previous Transplant, PRA Score, CMV Status, Hepatitis B and C Status, BMI, Blood Pressure, Cholesterol, Triglycerides, Diabetes Status,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Race/Ethnicity",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Patient Body Mass Index (BMI)",
          "BMI"
        ],
        [
          "Patient Panel Reactive Antibody (PRA)(%)",
          "PRA Score"
        ],
        [
          "Donor/Recipient High-Risk CMV Serostatus",
          "CMV Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Donor type",
        "Deceased-donor Cold Ischemia Time",
        "Donor/recipient height ratio",
        "Donor age",
        "Donor gender",
        "Donor BMI",
        "Donor final serum creatinine",
        "Adult Cadaver Donor Nyberg Grade",
        "Pediatric vs. Adult Donor"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Cause of End-Stage Renal Disease",
        "Duration of Dialysis",
        "Previous Transplant",
        "Hepatitis B and C Status",
        "Blood Pressure",
        "Cholesterol",
        "Triglycerides",
        "Diabetes Status"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), primary cause of end-stage renal disease, duration of dialysis, previous transplant history, panel reactive antibody (PRA) score, cytomegalovirus (CMV) serostatus, hepatitis B and C serostatus, donor type (deceased or living), donor age, cold ischemia time, warm ischemia time.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Patient Body Mass Index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Patient Panel Reactive Antibody (PRA)(%)",
          "panel reactive antibody (PRA) score"
        ],
        [
          "Donor type",
          "donor type (deceased or living)"
        ],
        [
          "Donor age",
          "donor age"
        ],
        [
          "Deceased-donor Cold Ischemia Time",
          "cold ischemia time"
        ],
        [
          "Donor/Recipient High-Risk CMV Serostatus",
          "cytomegalovirus (CMV) serostatus"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Donor/recipient height ratio",
        "Donor gender",
        "Donor BMI",
        "Donor final serum creatinine",
        "Adult Cadaver Donor Nyberg Grade",
        "Pediatric vs. Adult Donor"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "weight",
        "height",
        "primary cause of end-stage renal disease",
        "duration of dialysis",
        "previous transplant history",
        "hepatitis B and C serostatus",
        "warm ischemia time"
      ]
    }
  }
}